Deep Vein Thrombosis (DVT) Pumps Market Size, Share, Growth, and Industry Analysis, By Type (Lower Extremity,Upper Extremity), By Application (Hospitals,Surgical Centers), Regional Insights and Forecast to 2035

Deep Vein Thrombosis (DVT) Pumps Market Overview

The global Deep Vein Thrombosis (DVT) Pumps Market size is projected to grow from USD 470.76 million in 2026 to USD 491.95 million in 2027, reaching USD 700 million by 2035, expanding at a CAGR of 4.5% during the forecast period.

The global Deep Vein Thrombosis (DVT) Pumps Market reached shipments of more than 4.8 million units in 2024, supporting treatment in hospitals, surgical centers, and home care. Lower extremity pumps represented 72 percent of demand, while upper extremity pumps accounted for 28 percent. By application, hospitals made up 58 percent of use, surgical centers 30 percent, and other healthcare facilities 12 percent. North America consumed 38 percent of global units, Europe 27 percent, Asia-Pacific 28 percent, and Middle East & Africa 7 percent. Aging populations and surgical procedures exceeding 310 million annually drove demand.

USA market: The United States accounted for nearly 32 percent of global demand in 2024, with shipments exceeding 1.5 million units. Hospitals represented 60 percent of national consumption, surgical centers 28 percent, and other facilities 12 percent. Around 900,000 devices were used in orthopedic and cardiovascular procedures annually. Lower extremity pumps made up 75 percent of demand, while upper extremity accounted for 25 percent. Leading suppliers such as ArjoHuntleigh, Cardinal Health, and Zimmer Biomet controlled 55 percent of US market share. The prevalence of venous thromboembolism, affecting 900,000 Americans annually, continued to strengthen product adoption.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 72 percent of global demand came from lower extremity DVT pumps in 2024, with hospitals accounting for 58 percent of use.
• Major Market Restraint: 26 percent of smaller facilities delayed adoption due to device costs, with average procurement costs rising 12 percent from 2022–2024.
• Emerging Trends: 18 percent of DVT pumps shipped in 2024 had digital monitoring features, up from 10 percent in 2022.
• Regional Leadership: North America led with 38 percent of global shipments, followed by Europe at 27 percent, Asia-Pacific 28 percent, and MEA 7 percent.
• Competitive Landscape: Top five players controlled 57 percent of the market, with ArjoHuntleigh and Cardinal Health together holding 30 percent.
• Market Segmentation: By type, lower extremity pumps 72 percent, upper extremity pumps 28 percent; By application, hospitals 58 percent, surgical centers 30 percent.
• Recent Development: Wireless DVT pumps accounted for 15 percent of new installations in 2024, up from 7 percent in 2021.

Deep Vein Thrombosis (DVT) Pumps Market Latest Trends

The Deep Vein Thrombosis (DVT) Pumps Market Market Trends are shaped by rising surgical volumes, digital integration, and preventive healthcare adoption. In 2024, over 310 million surgical procedures were performed worldwide, each requiring prophylaxis against thromboembolism. Hospitals represented 58 percent of pump usage, surgical centers 30 percent, and others 12 percent. Lower extremity devices dominated at 72 percent, used extensively in orthopedic, cardiovascular, and general surgeries.

Deep Vein Thrombosis (DVT) Pumps Market Dynamics

Driver

"Rising surgical procedures and prevention requirements."

Over 310 million surgical procedures globally in 2024 demanded prophylaxis, with 58 percent of hospitals integrating DVT pumps. In the US alone, 900,000 venous thromboembolism cases annually drove hospitals to use 1.5 million pumps. Orthopedic surgeries accounted for 35 percent of DVT pump usage, cardiovascular 20 percent, and general surgeries 15 percent. With lower extremity pumps comprising 72 percent of demand, the driver of growth is strong adoption in high-risk surgery prevention.

Restraint

"High costs and uneven affordability across facilities."

Around 26 percent of smaller healthcare providers delayed purchasing DVT pumps due to procurement expenses rising 12 percent between 2022 and 2024. Device maintenance costs increased by 10 percent, and training raised expenses by another 8 percent. In Middle East & Africa, which held only 7 percent of demand, affordability was a critical barrier. Smaller surgical centers, representing 30 percent of global demand, often sought refurbished units to reduce costs, restraining premium product growth.

Opportunity

"Digital monitoring and portable DVT pumps."

Digital features were included in 18 percent of pumps shipped in 2024, with connectivity allowing real-time patient monitoring. Portable devices for home-based care grew by 12 percent year-on-year in 2023, with 500,000 households adopting them. Asia-Pacific accounted for 40 percent of portable demand, while North America held 35 percent. Wireless systems represented 15 percent of shipments in 2024, enabling expanded use in ambulatory surgical centers. Healthcare providers increasingly viewed DVT pumps as part of digital patient management strategies.

Challenge

"Compliance and counterfeit risks."

Around 10 percent of devices in circulation globally in 2023 were identified as non-compliant or unregulated. Counterfeit pumps accounted for 4 percent of shipments in Europe, raising safety risks. In Asia-Pacific, 12 percent of small providers reported quality issues with imported devices. Ensuring compliance added 7 percent to operational costs for major players, while regulatory delays slowed approval timelines by 6 months in some regions.

Deep Vein Thrombosis (DVT) Pumps Market Segmentation

Lower extremity pumps dominated with 72 percent of global demand in 2024, representing 3.4 million units, while upper extremity pumps held 28 percent at 1.3 million units. By application, hospitals led with 58 percent, surgical centers 30 percent, and other facilities 12 percent. Orthopedic surgeries alone consumed 35 percent of pumps, followed by cardiovascular at 20 percent. Wireless and portable devices together made up 15 percent of new shipments, while 18 percent featured digital monitoring capabilities.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Lower Extremity: Lower extremity pumps dominated with 72 percent share in 2024, representing over 3.4 million units. Orthopedic procedures drove 40 percent of usage, while cardiovascular accounted for 20 percent. North America consumed 38 percent of these units, Europe 27 percent, and Asia-Pacific 28 percent.

The lower extremity pumps segment is valued at USD 337.87 million in 2025, accounting for 75% share, and is forecasted to reach USD 502.11 million by 2034, growing at a CAGR of 4.48% supported by hospital-driven adoption.

Top 5 Major Dominant Countries in the Lower Extremity Segment

• United States: USD 84.47 million in 2025, 25% share and 4.50% CAGR, supported by orthopedic surgery and post-operative recovery usage.
• Germany: USD 47.30 million in 2025, 14% share and 4.47% CAGR, influenced by vascular disorder treatment and surgical interventions.
• China: USD 44.86 million in 2025, 13% share and 4.53% CAGR, fueled by rising hospital admissions and surgical procedures.
• Japan: USD 37.17 million in 2025, 11% share and 4.46% CAGR, with growing demand in elderly care management.
• India: USD 30.41 million in 2025, 9% share and 4.54% CAGR, supported by expanding healthcare facilities and surgical centers.

Upper Extremity: Upper extremity pumps represented 28 percent of global shipments, around 1.3 million units in 2024. They were heavily used in post-mastectomy care and trauma recovery. Hospitals consumed 65 percent of these units, surgical centers 25 percent, and other facilities 10 percent.

The upper extremity pumps segment is projected at USD 112.62 million in 2025, representing 25% share, and expected to rise to USD 167.38 million by 2034, growing at a CAGR of 4.52% driven by targeted vascular therapies.

Top 5 Major Dominant Countries in the Upper Extremity Segment

• United States: USD 28.15 million in 2025, 25% share and 4.53% CAGR, led by growing upper limb venous disorder treatments.
• China: USD 22.52 million in 2025, 20% share and 4.56% CAGR, supported by higher diagnostic rates and hospital-driven usage.
• Germany: USD 16.89 million in 2025, 15% share and 4.50% CAGR, with demand from vascular care.
• Japan: USD 13.51 million in 2025, 12% share and 4.48% CAGR, influenced by aging population medical needs.
• India: USD 10.13 million in 2025, 9% share and 4.57% CAGR, with increased adoption in specialty surgical centers.

BY APPLICATION

Hospitals: Hospitals accounted for 58 percent of demand, around 2.8 million units in 2024. Around 900,000 units were used annually in US hospitals. Europe consumed 30 percent, Asia-Pacific 28 percent, and MEA 12 percent.

Hospitals application segment is valued at USD 292.82 million in 2025, representing 65% share, and is expected to grow at 4.51% CAGR, driven by post-operative care requirements and inpatient treatment protocols.

Top 5 Major Dominant Countries in the Hospitals Application

• United States: USD 76.13 million in 2025, 26% share and 4.53% CAGR, supported by orthopedic and cardiovascular surgery usage.
• Germany: USD 43.92 million in 2025, 15% share and 4.49% CAGR, influenced by strict surgical safety protocols.
• China: USD 41.00 million in 2025, 14% share and 4.54% CAGR, led by healthcare infrastructure expansion.
• Japan: USD 32.21 million in 2025, 11% share and 4.47% CAGR, supported by elderly surgical care.
• India: USD 26.35 million in 2025, 9% share and 4.55% CAGR, fueled by hospital expansion in tier-2 cities.

Surgical Centers: Surgical centers made up 30 percent of demand, about 1.4 million units. Ambulatory centers in North America accounted for 35 percent of this share, while Europe and Asia-Pacific represented 25 percent each. Portable and wireless devices accounted for 20 percent of this segment.

Surgical centers are projected at USD 157.67 million in 2025, accounting for 35% share, and forecasted to grow at 4.47% CAGR, supported by outpatient surgeries and short-stay procedures requiring DVT prevention devices.

Top 5 Major Dominant Countries in the Surgical Centers Application

• United States: USD 41.99 million in 2025, 27% share and 4.50% CAGR, driven by outpatient orthopedic and bariatric surgeries.
• China: USD 35.49 million in 2025, 23% share and 4.55% CAGR, fueled by surgical center expansion.
• Germany: USD 25.06 million in 2025, 16% share and 4.48% CAGR, supported by minimally invasive procedures.
• Japan: USD 18.47 million in 2025, 12% share and 4.46% CAGR, influenced by high surgical volumes.
• India: USD 15.18 million in 2025, 10% share and 4.56% CAGR, with rising demand in specialty surgical care.

Deep Vein Thrombosis (DVT) Pumps Market Regional Outlook

North America led with 38 percent of global demand in 2024, with the USA accounting for 80 percent and 1.5 million units. Europe followed at 27 percent, driven by Germany, France, and the UK, with 35 percent of devices wireless-enabled. Asia-Pacific held 28 percent, with China and India making up 55 percent of regional demand and 40 percent of portable device adoption. Middle East & Africa contributed 7 percent, dominated by UAE and Saudi Arabia at 65 percent, with 20 percent of devices being refurbished imports.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America accounted for 38 percent of global DVT pump demand in 2024. The USA represented 80 percent of this share, Canada 12 percent, and Mexico 8 percent. Hospitals dominated with 60 percent of usage, followed by surgical centers at 28 percent. Around 1.5 million pumps were installed in US healthcare systems. ArjoHuntleigh, Cardinal Health, and Zimmer Biomet held 55 percent combined share.

North America is projected at USD 148.66 million in 2025, representing 33% share and 4.51% CAGR, led by hospitals and outpatient centers focusing on preventive post-surgical care.

North America - Major Dominant Countries in the Deep Vein Thrombosis (DVT) Pumps Market Market

• United States: USD 115.92 million in 2025, 78% share and 4.53% CAGR, dominating due to high surgical procedure volumes.
• Canada: USD 14.86 million in 2025, 10% share and 4.49% CAGR, supported by healthcare modernization.
• Mexico: USD 11.89 million in 2025, 8% share and 4.50% CAGR, influenced by hospital expansions.
• Puerto Rico: USD 2.97 million in 2025, 2% share and 4.46% CAGR, with niche surgical adoption.
• Dominican Republic: USD 2.97 million in 2025, 2% share and 4.45% CAGR, supported by healthcare equipment imports.

EUROPE

Europe held 27 percent of global demand. Germany, France, and the UK together represented 65 percent of shipments. Hospitals accounted for 55 percent of European usage, surgical centers 30 percent, and others 15 percent. Around 35 percent of European pumps had wireless connectivity in 2024. ArjoHuntleigh was a leading supplier, covering 25 percent of the European market.

Europe is valued at USD 126.14 million in 2025, representing 28% share and 4.48% CAGR, supported by high standards in surgical safety and vascular care equipment adoption.

Europe - Major Dominant Countries in the Deep Vein Thrombosis (DVT) Pumps Market Market

• Germany: USD 37.84 million in 2025, 30% share and 4.49% CAGR, leading in hospital demand.
• United Kingdom: USD 25.23 million in 2025, 20% share and 4.47% CAGR, supported by NHS-driven adoption.
• France: USD 20.18 million in 2025, 16% share and 4.46% CAGR, influenced by surgical recovery demand.
• Italy: USD 15.14 million in 2025, 12% share and 4.45% CAGR, supported by orthopedic procedures.
• Spain: USD 12.61 million in 2025, 10% share and 4.44% CAGR, with increased healthcare spending.

ASIA-PACIFIC

Asia-Pacific contributed 28 percent of global shipments. China and India together made up 55 percent of regional demand, while Japan and South Korea added 20 percent. Hospitals represented 60 percent of usage, surgical centers 28 percent, and others 12 percent. Around 40 percent of portable pump demand originated in Asia-Pacific.

Asia is projected at USD 121.64 million in 2025, representing 27% share and 4.55% CAGR, fueled by growing hospital infrastructure, rising surgeries, and expanding elderly populations.

Asia - Major Dominant Countries in the Deep Vein Thrombosis (DVT) Pumps Market Market

• China: USD 42.57 million in 2025, 35% share and 4.56% CAGR, driven by hospital expansions.
• Japan: USD 29.19 million in 2025, 24% share and 4.47% CAGR, influenced by elderly surgical demand.
• India: USD 26.76 million in 2025, 22% share and 4.57% CAGR, supported by surgical centers.
• South Korea: USD 14.60 million in 2025, 12% share and 4.50% CAGR, with hospital-driven adoption.
• Indonesia: USD 8.52 million in 2025, 7% share and 4.53% CAGR, fueled by healthcare investments.

MIDDLE EAST & AFRICA

MEA accounted for 7 percent of global demand. The UAE and Saudi Arabia made up 65 percent of this share, while South Africa added 15 percent. Hospitals accounted for 55 percent of demand, surgical centers 30 percent, and others 15 percent. Around 20 percent of devices used in MEA were refurbished imports.

Middle East and Africa are valued at USD 54.05 million in 2025, representing 12% share and 4.46% CAGR, supported by healthcare infrastructure growth and demand for surgical safety devices.

Middle East and Africa - Major Dominant Countries in the Deep Vein Thrombosis (DVT) Pumps Market Market

• Saudi Arabia: USD 16.21 million in 2025, 30% share and 4.47% CAGR, supported by healthcare modernization.
• UAE: USD 12.43 million in 2025, 23% share and 4.48% CAGR, driven by hospital and surgical centers.
• South Africa: USD 8.11 million in 2025, 15% share and 4.45% CAGR, with increased adoption in hospitals.
• Egypt: USD 6.48 million in 2025, 12% share and 4.44% CAGR, influenced by healthcare modernization programs.
• Nigeria: USD 5.41 million in 2025, 10% share and 4.46% CAGR, with demand from expanding surgical facilities.

List of Top Deep Vein Thrombosis (DVT) Pumps Companies

• ArjoHuntleigh
• Breg
• Mego Afek AC LTD
• Currie Medical Specialties
• Cardinal Health
• ThermoTek USA
• Normatec
• DJO
• Devon Medical Products
• Bio Compression Systems
• Zimmer Biomet

Top Two Companies by Highest Market Share:

• ArjoHuntleigh held 18 percent of global shipments in 2024.
• Cardinal Health accounted for 12 percent, with dominance in North America and Europe.

Investment Analysis and Opportunities

Global investments focused on digital and portable pump development. Around 18 percent of pumps shipped in 2024 had digital monitoring features. North America accounted for 35 percent of total investment, Asia-Pacific 30 percent, Europe 25 percent, and MEA 10 percent. Around 500,000 households worldwide adopted portable pumps, with Asia-Pacific leading at 40 percent. Capital was directed to orthopedic and cardiovascular applications, which together accounted for 55 percent of installations.

New Product Development

Between 2023 and 2024, 50 new DVT pump models were launched. Around 18 percent integrated hospital network monitoring, and 15 percent offered wireless portability. ArjoHuntleigh introduced a smart pump with 20 percent lower noise output. Cardinal Health launched wireless systems reducing setup time by 25 percent. Zimmer Biomet released orthopedic-focused pumps, used in 200,000 surgeries in 2024. Devon Medical developed portable devices with 18 percent reduced power consumption.

Five Recent Developments

• ArjoHuntleigh launched a digital monitoring pump in 2023, reducing hospital monitoring costs by 12 percent.
• Cardinal Health expanded wireless systems, reaching 15 percent of US installations in 2024.
• Zimmer Biomet supplied orthopedic DVT pumps for 200,000 surgeries in 2024.
• Devon Medical launched portable pumps with 18 percent lower energy use in 2023.
• Asia-Pacific recorded 40 percent of portable pump adoption in 2024.

Report Coverage

The Deep Vein Thrombosis (DVT) Pumps Market Market Report covers shipments of 4.8 million units in 2024. By type: lower extremity pumps 72 percent, upper extremity pumps 28 percent. By application: hospitals 58 percent, surgical centers 30 percent, others 12 percent. Regional distribution: North America 38 percent, Europe 27 percent, Asia-Pacific 28 percent, and MEA 7 percent. The USA accounted for 32 percent of global demand with 1.5 million units. ArjoHuntleigh and Cardinal Health together held 30 percent global share. Wireless and portable devices represented 15 percent of new shipments, while digital monitoring features accounted for 18 percent. The report provides Deep Vein Thrombosis (DVT) Pumps Market Market Insights, Market Analysis, Market Forecast, Market Trends, and Market Opportunities for B2B stakeholders.

Deep Vein Thrombosis (DVT) Pumps Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 470.76 Million in 2026
Market Size Value By	USD 700 Million by 2035
Growth Rate	CAGR of 4.5% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Lower Extremity Upper Extremity By Application : Hospitals Surgical Centers
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample